Corrigendum: Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features

Corrigendum: Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features

Saved in:

Bibliographic Details
Main Authors:	Reivla Marques Vasconcelos Soares, Monique Alvares da Silva, Julliane Tamara Araújo de Melo Campos, Josivan Gomes Lima
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Endocrinology
Subjects:	PPAR gamma adipose tissue genetic lipodystrophy insulin resistance diabetes mellitus
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2024.1508146/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Familial partial lipodystrophy resulting from loss-of-function PPARγ pathogenic variants: phenotypic, clinical, and genetic features
by: Reivla Marques Vasconcelos Soares, et al.
Published: (2024-09-01)

Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
by: Rosińska Kamila Rosińska, et al.
Published: (2025-02-01)

A very low carbohydrate diet improved metabolic profile in congenital generalized lipodystrophy type 4
by: Sayantan Chakraborty, et al.
Published: (2025-01-01)

Treatment of facial lipodystrophy induced by a biologic agent (IPD-1): a literature review
by: Henri Friedhofer, et al.
Published: (2024-11-01)

Editorial: Improving diagnosis and management of genetic lipodystrophy
by: Milena Teles, et al.
Published: (2025-01-01)

Serum Leucine-Rich Alpha-2 Glycoprotein 1 Levels in Patients with Lipodystrophy Syndromes
by: Michelle Krienke, et al.
Published: (2024-11-01)

Metabolic Activity in Human Intermuscular Adipose Tissue Directs the Response of Resident PPARγ<sup>+</sup> Macrophages to Fatty Acids
by: Xiaoying Chen, et al.
Published: (2024-12-01)

Acquired lipodystrophy following use of pembrolizumab
by: Maya Weitzen, et al.
Published: (2024-12-01)

Case Report: Concurrent de novo pathogenic variants in the LMNA gene as a cause of sporadic partial lipodystrophy
by: José L. Santos, et al.
Published: (2024-11-01)

Understanding Adipose Tissue Dysfunction
by: Matthias Blüher
Published: (2024-12-01)

Lipedema: exploring pathophysiology and treatment strategies – state of the art
by: Fabio Kamamoto, et al.
Published: (2025-01-01)

Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-γ and acetyl-CoA-carboxylase 1
by: Swetha Peesari, et al.
Published: (2024-12-01)

Involvement of a battery of investigated genes in lipid droplet pathophysiology and associated comorbidities
by: Sami N. Al Harake, et al.
Published: (2024-12-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

PPARγ/ETV2 axis regulates endothelial‐to‐mesenchymal transition in pulmonary hypertension
by: Dong Hun Lee, et al.
Published: (2024-10-01)

BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis
by: Yanxing Mai, et al.
Published: (2024-11-01)

PPAR-γ抑制剂T0070907对人鼻咽癌细胞的生长抑制作用
Published: (2010-01-01)

Antidiabetic Effect of Dihydrobetulonic Acid Derivatives as Pparα/γ Agonists
by: Mikhail V. Khvostov, et al.
Published: (2024-12-01)

Exacerbation of atherosclerosis, hyperlipidemia and inflammation by MK886, an inhibitor of leukotriene biosynthesis, in obese and diabetic mice
by: Katherine Keever, et al.
Published: (2024-01-01)

Bexarotene ameliorated the pulmonary inflammation and M1 polarization of alveolar macrophages induced by cigarette smoke via PPARγ/HO-1
by: Haoshen Feng, et al.
Published: (2024-12-01)

Kadın futbolcularda PPAR-Alpha geni polimorfiziminin incelenmesi
by: Faruk Bozyurt, et al.
Published: (2024-12-01)

Integrative in-silico and in-vitro analysis of taurine and vitamin B12 in modulating PPARγ and Wnt signaling in hyperhomocysteinemia-induced osteoporosis
by: Mazumder Adhish, et al.
Published: (2024-12-01)

Slow Metabolism–Driven Amplification of Hepatic PPARγ Agonism Mediates Benzbromarone‐Induced Obesity‐Specific Liver Injury
by: Guanting Li, et al.
Published: (2025-01-01)

Exploring Seipin: From Biochemistry to Bioinformatics Predictions
by: Aquiles Sales Craveiro Sarmento, et al.
Published: (2018-01-01)

Fermented sugarcane juice-derived probiotic Levilactobacillus brevis RAMULAB54 enhances lipid metabolism and glucose homeostasis through PPAR-γ activation
by: V. B. Chandana Kumari, et al.
Published: (2025-01-01)

CANDLE syndrome – a narrative review
by: Aleksandra Snopkowska, et al.
Published: (2024-09-01)

Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available clinicopathological parameters
by: Asmaa E. Bedeer, et al.
Published: (2023-07-01)

Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia
by: Hongpeng Duan, et al.
Published: (2024-12-01)

Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) from a Young Age Due to a Rare Genetic Disorder, Familial Partial Lipodystrophy: A Case Report and Review of the Literature
by: Elena Vorona, et al.
Published: (2024-12-01)

PPARγ activation ameliorates PM2.5-induced renal tubular injury by inhibiting ferroptosis and epithelial–mesenchymal transition
by: Chien-Hung Lin, et al.
Published: (2024-01-01)

PPARγ activation attenuates neonatal CRD-induced visceral pain sensitization and anxiety in male rats by alleviating oxidative stress
by: Minjie Li, et al.
Published: (2025-01-01)

The therapeutic effects of curcumin on polycystic ovary syndrome by upregulating PPAR-γ expression and reducing oxidative stress in a rat model
by: Wei Zhang, et al.
Published: (2024-11-01)

Modulation of adiposity and adipocyte inflammation by methanol extracts of Alpinia calcarata leaf in high-fat-diet induced-obese mice: Involvement of COX-2 and PPAR-γ
by: Imtiaz Ahmad, et al.
Published: (2025-01-01)

Pemafibrate Induces a Low Level of PPARα Agonist-Stimulated mRNA Expression of ANGPTL4 in ARPE19 Cell
by: Hiroshi Ohguro, et al.
Published: (2024-12-01)

The role of PPAR in fungal keratitis
by: Hongyan Zhou, et al.
Published: (2024-12-01)

Anti-diabetic and anti-inflammatory activities of Marrubiin isolated from Marrubium vulgare: Indications of its interaction with PPAR γ
by: Parveen Kumar, et al.
Published: (2024-11-01)

Targeting TCMR-associated cytokine genes for drug screening identifies PPARγ agonists as novel immunomodulatory agents in transplantation
by: Lu Hu, et al.
Published: (2025-01-01)

In silico and cheminformatics prediction with experimental validation of an adipogenesis cocktail, sorafenib with rosiglitazone for HCC dedifferentiation
by: Aya Anis, et al.
Published: (2024-12-01)

Conjugated linoleic acid ameliorates necrotizing enterocolitis by suppressing inflammatory responses and maintaining intestinal barrier integrity via the PPARγ/NFκB signaling pathway
by: Chengyao Jiang, et al.
Published: (2024-12-01)

The impact of PPARγ and ApoE gene polymorphisms on susceptibility to diabetic kidney disease in type 2 diabetes mellitus: a meta-analysis
by: Binura Taurbekova, et al.
Published: (2024-11-01)